SCM
IDXX icon

Sandler Capital Management’s Idexx Laboratories IDXX Stock Holding History

Sandler Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,965
Closed -$1.1M – 146
2026
Q1 		$1.1M Buy
1,965
+413
+27% +$265K 0.57% 63
2025
Q4 		$1.05M Sell
1,552
-808
-34% -$550K 0.34% 105
2025
Q3 		$1.51M Buy
+2,360
New +$1.43M 0.44% 82
2017
Q2 		– Sell
-32,747
Closed -$5.06M – 160
2017
Q1 		$5.06M Sell
32,747
-19,983
-38% -$2.75M 0.35% 112
2016
Q4 		$6.18M Buy
+52,730
New +$6.02M 0.55% 79

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sandler Capital Management's IDXX Position: Q2 2026 in Review

Sandler Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 1,965 shares — an estimated $1.1M sold.

Sandler Capital Management first reported a position in IDXX in Q4 2016 and held it in 5 quarters. The position peaked at $6.18M in Q4 2016. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sandler Capital Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Sandler Capital Management sold 1,965 Idexx Laboratories shares in Q2 2026, an estimated $1.1M.
  • Sandler Capital Management first reported a position in Idexx Laboratories in Q4 2016 and held it in 5 quarters.
  • Sandler Capital Management's Idexx Laboratories position peaked at $6.18M in Q4 2016.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sandler Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.